연구성과로 돌아가기
JCR 2023 저널 목록 (400 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFRICA | CAMBRIDGE UNIV PRESS | 0001-9720 | 1750-0184 | SSCI | AREA STUDIES | 1,400 | 1.2 | Q1 | 20.7 | 79.3 | 37/176 | 1.3 | Q2 | 1.1 | 0.5 | 0.86 | 72/176 | Q2 | 59.38 | 0.001 | 0.251 | 0.668 | Q2 | 30 | 96.7% | 17.7 | 10.7 | 29 | 42.6% | 2025-03-24 16:54:12 | 바로가기 |
| ANTIVIRAL RESEARCH | ELSEVIER | 0166-3542 | 1872-9096 | SCIE | VIROLOGY | 11,998 | 4.5 | Q1 | 20.7 | 79.3 | 9/41 | 5.0 | Q1 | 4.3 | 1.1 | 1.75 | 3/41 | Q1 | 93.90 | 0.010 | 2.201 | 1.276 | Q1 | 185 | 99.5% | 7.3 | 5.9 | 184 | 34.6% | 2025-03-24 18:15:36 | 바로가기 |
| Asian Studies Review | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 1035-7823 | 1467-8403 | SSCI | AREA STUDIES | 730 | 1.2 | Q1 | 20.7 | 79.3 | 37/176 | 1.6 | Q1 | 1.1 | 0.1 | 1.81 | 17/176 | Q1 | 90.63 | 0.001 | 0.204 | 0.557 | Q2 | 41 | 100.0% | 6.9 | 11.0 | 41 | 13.8% | 2025-03-24 16:54:15 | 바로가기 |
| Biosafety and Health | ELSEVIER | 2096-6962 | 2590-0536 | ESCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 584 | 3.5 | Q1 | 20.7 | 79.3 | 85/408 | N/A | N/A | 3.3 | 0.9 | 1.31 | 48/408 | Q1 | 88.36 | 0.001 | 0.217 | N/A | N/A | 47 | 63.8% | 2.4 | 4.0 | 30 | 96.0% | 2025-03-24 18:07:22 | 바로가기 |
| BMC Medical Ethics | BMC | 1472-6939 | 1472-6939 | SSCI | SOCIAL SCIENCES, BIOMEDICAL | 3,514 | 3.0 | Q1 | 20.7 | 79.3 | 10/46 | 3.1 | Q1 | 2.8 | 0.5 | 1.04 | 14/46 | Q2 | 70.65 | 0.005 | 1.165 | 1.023 | Q2 | 104 | 86.5% | 5.1 | 7.4 | 90 | 100.0% | 2025-03-24 18:10:19 | 바로가기 |
| BMC PUBLIC HEALTH | BMC | N/A | 1471-2458 | SCIE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 71,479 | 3.5 | Q1 | 20.7 | 79.3 | 85/408 | 3.9 | Q1 | 3.3 | 0.6 | 1.10 | 74/408 | Q1 | 81.99 | 0.089 | 19.518 | 1.117 | Q2 | 2506 | 93.7% | 5.4 | 6.2 | 2349 | 99.9% | 2025-03-24 18:06:39 | 바로가기 |
| China Review-An Interdisciplinary Journal on Greater China | CHINESE UNIV PRESS | 1680-2012 | 1680-2012 | SSCI | AREA STUDIES | 678 | 1.2 | Q1 | 20.7 | 79.3 | 37/176 | 1.9 | Q1 | 1.2 | 1.2 | 1.76 | 18/176 | Q1 | 90.06 | 0.001 | 0.256 | 0.827 | Q1 | 25 | 100.0% | 5.7 | 5.7 | 25 | 0.0% | 2025-03-24 16:54:15 | 바로가기 |
| Dermatology and Therapy | ADIS INT LTD | 2193-8210 | 2190-9172 | SCIE | DERMATOLOGY | 2,958 | 3.5 | Q1 | 20.7 | 79.3 | 20/94 | 3.6 | Q1 | 3.2 | 0.8 | 1.06 | 19/94 | Q1 | 80.32 | 0.005 | 1.119 | 1.000 | Q1 | 187 | 75.9% | 3.0 | 5.8 | 142 | 98.8% | 2025-03-24 17:03:59 | 바로가기 |
| Diabetes & Metabolic Syndrome-Clinical Research & Reviews | ELSEVIER SCI LTD | 1871-4021 | 1878-0334 | ESCI | ENDOCRINOLOGY & METABOLISM | 8,464 | 4.3 | Q1 | 20.7 | 79.3 | 39/186 | 4.7 | Q1 | 4.3 | 0.8 | 1.84 | 13/186 | Q1 | 93.28 | 0.013 | 2.749 | 0.996 | Q2 | 131 | 67.9% | 3.7 | 5.9 | 89 | 4.6% | 2025-03-24 17:07:34 | 바로가기 |
| East Asia | SPRINGERNATURE | 1096-6838 | 1874-6284 | ESCI | AREA STUDIES | 246 | 1.2 | Q1 | 20.7 | 79.3 | 37/176 | 1.1 | Q2 | 1.0 | 0.8 | 1.02 | 59/176 | Q2 | 66.76 | 0.000 | 0.075 | 0.407 | Q2 | 22 | 100.0% | 5.9 | 5.2 | 22 | 24.2% | 2025-03-24 16:54:20 | 바로가기 |
| EMBO REPORTS | WILEY | 1469-221X | 1469-3178 | SCIE | CELL BIOLOGY | 20,124 | 6.5 | Q1 | 20.7 | 79.3 | 43/205 | 8.3 | Q1 | 6.5 | 1.1 | 1.10 | 49/205 | Q1 | 76.34 | 0.026 | 5.796 | 3.275 | Q1 | 250 | 94.0% | 7.4 | 8.3 | 235 | 55.8% | 2025-03-24 16:58:31 | 바로가기 |
| EUROPE-ASIA STUDIES | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0966-8136 | 1465-3427 | SSCI | AREA STUDIES | 1,836 | 1.2 | Q1 | 20.7 | 79.3 | 37/176 | 1.7 | Q1 | 1.1 | 0.3 | 0.82 | 77/176 | Q2 | 56.53 | 0.002 | 0.542 | 0.828 | Q1 | 56 | 98.2% | 8.6 | 8.8 | 55 | 24.6% | 2025-03-24 16:54:11 | 바로가기 |
| EVOLUTION AND HUMAN BEHAVIOR | ELSEVIER SCIENCE INC | 1090-5138 | 1879-0607 | SSCI | SOCIAL SCIENCES, BIOMEDICAL | 4,847 | 3.0 | Q1 | 20.7 | 79.3 | 10/46 | 3.7 | Q1 | 2.7 | 1.2 | 1.39 | 7/46 | Q1 | 85.87 | 0.004 | 0.778 | 1.465 | Q1 | 51 | 98.0% | 11.3 | 13.9 | 50 | 21.3% | 2025-03-24 18:10:18 | 바로가기 |
| EXPERIMENTAL DERMATOLOGY | WILEY | 0906-6705 | 1600-0625 | SCIE | DERMATOLOGY | 9,302 | 3.5 | Q1 | 20.7 | 79.3 | 20/94 | 4.0 | Q1 | 3.3 | 0.7 | 1.27 | 14/94 | Q1 | 85.64 | 0.009 | 1.897 | 1.079 | Q1 | 220 | 83.2% | 7.2 | 7.0 | 183 | 24.5% | 2025-03-24 17:03:55 | 바로가기 |
| Expert Review of Vaccines | TAYLOR & FRANCIS LTD | 1476-0584 | 1744-8395 | SCIE | IMMUNOLOGY | 5,991 | 5.5 | Q1 | 20.7 | 79.3 | 38/181 | 5.4 | Q1 | 5.4 | 0.8 | 0.79 | 66/181 | Q2 | 63.81 | 0.006 | 1.338 | 1.437 | Q2 | 82 | 50.0% | 6.4 | 5.2 | 41 | 49.6% | 2025-03-24 17:20:14 | 바로가기 |
페이지 이동: